Correspondence 0000950170-24-085478 from Aspira Women's Health Inc. (AWHL)
Aspira Women's Health Inc.
Date: July 23, 2024 · CIK: 0000926617 · Accession: 0000950170-24-085478
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-280848
Letter
Aspira Women’s Health, Inc.
12117 Bee Caves Road, Building III, Suite 100
Austin, Texas
July 23, 2024
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Doris Stacey Gama
Re:
Aspira Women’s Health, Inc.
Registration Statement on Form S-3
Filed July 17, 2024
File No. 333-280848
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Aditxt, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Daylight Time, on Wednesday July 24, 2024, or as soon thereafter as possible.
Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
ASPIRA WOMEN’S HEALTH, INC.
By:
/s/ Nicole Sandford
Name:
Nicole Sandford
Title:
Chief Executive Officer
SMRH:4874-8036-4499.1
-1-
96WD-393779
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
Aspira Women’s Health, Inc.
12117 Bee Caves Road, Building III, Suite 100
Austin, Texas
July 23, 2024
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Doris Stacey Gama
Re:
Aspira Women’s Health, Inc.
Registration Statement on Form S-3
Filed July 17, 2024
File No. 333-280848
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Aditxt, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Daylight Time, on Wednesday July 24, 2024, or as soon thereafter as possible.
Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
ASPIRA WOMEN’S HEALTH, INC.
By:
/s/ Nicole Sandford
Name:
Nicole Sandford
Title:
Chief Executive Officer
SMRH:4874-8036-4499.1
-1-
072324
96WD-393779